Troglitazone and pioglitazone attenuate agonist‐dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells
Open Access
- 1 October 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 128 (3) , 673-683
- https://doi.org/10.1038/sj.bjp.0702818
Abstract
The effects of troglitazone and pioglitazone on agonist‐induced Ca2+ mobilization and cell proliferation were studied using fluorescent Ca2+ indicator fura‐2 AM and incorporation of [3H]‐thymidine in rat aortic smooth muscle cells. The patch clamp techniques were also employed. Vasopressin and platelet‐derived growth factor‐BB (PDGF) caused a transient elevation in [Ca2+]i by Ca2+ mobilization from intracellular stores, followed by a sustained rise due to Ca2+ entry. Nicardipine partly inhibited the sustained phase, but La3+ completely abolished it. Troglitazone and pioglitazone did not significantly affect the transient rise elicited by these agonists, but preferentially inhibited the sustained phase of [Ca2+]i. Under voltage clamp conditions, troglitazone and pioglitazone inhibited voltage‐dependent L‐type Ca2+ current (ICa·L). They also inhibited nonselective cation channels (Icat) elicited by vasopressin in a concentration‐dependent manner. The half maximal inhibitory concentrations of troglitazone on ICa·L and Icat were 4.6 and 5.7 μM, respectively. On the other hand, nifedipine and nicardipine did not inhibit Icat. Vasopressin and PDGF increased incorporation of [3H]‐thymidine, and nifedipine and nicardipine partly suppressed it. However, the inhibitory effects of La3+ and exclusion of extracellular Ca2+ were more potent than the Ca2+ blocking agents. Troglitazone and pioglitazone also inhibited it concentration‐dependently. These results suggest that troglitazone and pioglitazone preferentially inhibited agonist (vasopressin and PDGF)‐induced Ca2+ entry and proliferation in rat vascular smooth muscle cells, where the inhibitory effects of thiazolidinediones on ICa·L and Icat might be partly involved. Thus, thiazolidinediones may exert hypotensive and antiatherosclerotic effects. British Journal of Pharmacology (1999) 128, 673–683; doi:10.1038/sj.bjp.0702818Keywords
This publication has 61 references indexed in Scilit:
- Inhibitory effect of nitrovasodilators and cyclic GMP on ET‐1‐activated Ca2+‐permeable nonselective cation channel in rat aortic smooth muscle cellsBritish Journal of Pharmacology, 1997
- Attenuation of Hypertension by Insulin-Sensitizing AgentsHypertension, 1996
- Effects of pioglitazone on calcium channels in vascular smooth muscle.Hypertension, 1994
- Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle.Hypertension, 1993
- Stimulation of Calcium Entry Is Prerequisite for DNA Synthesis Induced by Platelet-Derived Growth Factor in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1993
- Effects of ciglitazone on blood pressure and intracellular calcium metabolism.Hypertension, 1993
- The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension.Hypertension, 1993
- Calcium influx modulates DNA synthesis and proliferation in A7r5 vascular smooth muscle cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells.Hypertension, 1989
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987